Brief: Okyo Pharma Announces Scientific Advisory Board Meeting And Urcosimod Data Presentation During Ascrs Annual Meeting
07/04/2026 12:29
April 7 (Reuters) - OKYO Pharma Ltd OK11.MU: OKYO PHARMA ANNOUNCES SCIENTIFIC ADVISORY BOARD MEETING AND URCOSIMOD DATA PRESENTATION DURING ASCRS ANNUAL MEETING Source text: ID:nGNX34yWj9 Further company coverage: OK11.MU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on OKYO Pharma
See all newsBrief: Okyo Pharma's Chairman Gabriele Cerrone Now Holds 20.55% Of Co's Issued Share Capital
Brief: Okyo Pharma Announces Scientific Advisory Board Meeting And Urcosimod Data Presentation During Ascrs Annual Meeting
Brief: Okyo Pharma Ltd Announces Pricing Of $20 Million Public Offering Of Ordinary Shares
Brief: OKYO Pharma To Offer Up To $200 Million In Securities
Brief: FDA Approves Compassionate Use Of Urcosimod (0.05%) For The Treatment Of Neuropathic Corneal Pain